Steinke-Lange V - Search Results

1

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays.

Hallermayr A, Keßler T, Fujera M, Liesfeld B, Bernstein S, von Ameln S, Schanze D, Steinke-Lange V, Pickl JMA, Neuhann TM, Holinski-Feder E. Hallermayr A, et al. Among authors: steinke lange v. Cancers (Basel). 2023 Oct 17;15(20):5024. doi: 10.3390/cancers15205024. Cancers (Basel). 2023. PMID: 37894392 Free PMC article.

2

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management.

Hallermayr A, Steinke-Lange V, Vogelsang H, Rentsch M, de Wit M, Haberl C, Holinski-Feder E, Pickl JMA. Hallermayr A, et al. Cancers (Basel). 2022 Feb 8;14(3):851. doi: 10.3390/cancers14030851. Cancers (Basel). 2022. PMID: 35159118 Free PMC article.

3

Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring.

Hallermayr A, Benet-Pagès A, Steinke-Lange V, Mansmann U, Rentsch M, Holinski-Feder E, Pickl JMA. Hallermayr A, et al. Clin Chem. 2021 Nov 1;67(11):1483-1491. doi: 10.1093/clinchem/hvab124. Clin Chem. 2021. PMID: 34392332

4

Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.

Hallermayr A, Wohlfrom T, Steinke-Lange V, Benet-Pagès A, Scharf F, Heitzer E, Mansmann U, Haberl C, de Wit M, Vogelsang H, Rentsch M, Holinski-Feder E, Pickl JMA. Hallermayr A, et al. J Hematol Oncol. 2022 Sep 2;15(1):125. doi: 10.1186/s13045-022-01342-z. J Hematol Oncol. 2022. PMID: 36056434 Free PMC article.

5

Genetic Screening and Personalized Prevention in Colorectal Cancer.

Steinke-Lange V, Holinski-Feder E. Steinke-Lange V, et al. Visc Med. 2019 Aug;35(4):226-230. doi: 10.1159/000501941. Epub 2019 Jul 17. Visc Med. 2019. PMID: 31602383 Free PMC article. Review.

6

[Hereditary non-polyposis tumor risk syndromes].

Steinke-Lange V, Holinski-Feder E. Steinke-Lange V, et al. MMW Fortschr Med. 2021 Jun;163(11):41-44. doi: 10.1007/s15006-021-9960-1. MMW Fortschr Med. 2021. PMID: 34086231 Review. German. No abstract available.

7

Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study.

Neuhann TM, Haub K, Steinke-Lange V, Morak M, Laner A, Locher M, Holinski-Feder E. Neuhann TM, et al. Fam Cancer. 2022 Oct;21(4):463-472. doi: 10.1007/s10689-022-00292-2. Epub 2022 May 16. Fam Cancer. 2022. PMID: 35570229

8

Transcript capture and ultradeep long-read RNA sequencing (CAPLRseq) to diagnose HNPCC/Lynch syndrome.

Schwenk V, Leal Silva RM, Scharf F, Knaust K, Wendlandt M, Häusser T, Pickl JMA, Steinke-Lange V, Laner A, Morak M, Holinski-Feder E, Wolf DA. Schwenk V, et al. J Med Genet. 2023 Aug;60(8):747-759. doi: 10.1136/jmg-2022-108931. Epub 2023 Jan 2. J Med Genet. 2023. PMID: 36593122 Free PMC article.

9

Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients.

Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K, Neuhann T, Abicht A, Steinke-Lange V, Holinski-Feder E. Henkel J, et al. Among authors: steinke lange v. Eur J Hum Genet. 2023 Aug;31(8):925-930. doi: 10.1038/s41431-023-01380-2. Epub 2023 May 15. Eur J Hum Genet. 2023. PMID: 37188824 Free PMC article.

10

Somatic mosaics in hereditary tumor predisposition syndromes.

Steinke-Lange V, de Putter R, Holinski-Feder E, Claes KB. Steinke-Lange V, et al. Eur J Med Genet. 2021 Dec;64(12):104360. doi: 10.1016/j.ejmg.2021.104360. Epub 2021 Oct 13. Eur J Med Genet. 2021. PMID: 34655802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page